Status: current, Defined. Date: 31-Oct 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4750391000168116 | elasomeran 25 microgram / 0.5 mL + imelasomeran 25 microgram / 0.5 mL injection, 2.5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4750401000168119 | elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4750491000168113 | COVID-19 mRNA-1273.214 bivalent vaccine injection, 2.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4750501000168118 | mRNA-1273.214 encoding SARS-CoV-2 spike protein injection, 2.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | Is a | elasomeran + imelasomeran | true | Inferred relationship | Some | ||
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1871034615 | |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | has Australian BoSS | elasomeran | true | Inferred relationship | Some | 157214196 | |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | has intended active ingredient | elasomeran | true | Inferred relationship | Some | 157214196 | |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | has intended active ingredient | imelasomeran | true | Inferred relationship | Some | 1256721046 | |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | has Australian BoSS | imelasomeran | true | Inferred relationship | Some | 1256721046 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Spikevax Bivalent Original/Omicron Multidose injection, 2.5 mL vial | Is a | True | elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | Inferred relationship | Some | |
| elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 10 x 2.5 mL vials | has MPUU | True | elasomeran 25 microgram/0.5 mL + imelasomeran 25 microgram/0.5 mL injection, 2.5 mL vial | Inferred relationship | Some | 947149575 |
Reference Sets
List of Excluded Medicinal Items reference set
Medicinal product unit of use reference set
FHIR